Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/16619
Title: Beta-blockers are under-prescribed in patients with chronic obstructive pulmonary disease and co-morbid cardiac disease
Authors: Neef, Pieter;McDonald, Christine F;Burrell, Louise M;Irving, LB;Johnson, DF;Steinfort, DP
Issue Date: Nov-2016
Citation: Internal Medicine Journal 2016; 46(11): 1336-1340
Abstract: The use of beta-blockers in patients with chronic obstructive pulmonary disease and co-morbid cardiovascular disease is controversial, despite increasing evidence to support their use as safe and efficacious. This study retrospectively assessed the rates of beta-blocker prescription in patients admitted to two Australian tertiary hospitals for acute exacerbation of chronic obstructive pulmonary disease. This revealed that less than half of patients (45%) with known cardiac indications were receiving beta-blocker therapy, evident across all degrees of airways disease severity. Further work is needed to ensure that medical management of this patient group is optimised.
URI: http://ahro.austin.org.au/austinjspui/handle/1/16619
DOI: 10.1111/imj.13240
ORCID: 0000-0003-1863-7539
PubMed URL: https://www.ncbi.nlm.nih.gov/pubmed/27813357
Type: Journal Article
Subjects: COPD
Beta-blocker
Cardiovascular disease
Chronic obstructive pulmonary disease
Drug Prescriptions
Adrenergic beta-Antagonists
Heart Failure
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.